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Nottlonk contrasi media are suggested tocause ittcreawl tbrom. 
boetttbolbnt (in viva?), platelet aggr@ion and promagulant o&t 
(in vitro) I( campared with tonic mttmt medta. To study these 
e8ect.s in viva, 30 Ntmecutive palientr undergoing muline *a&g. 
nphy ware pmspectively mdamired to Lm gmupr of 10 
priientr ead~. Group A mrivcd diatrizoate (i&c, high wnc4al. 
Ityh Grwp B ioxagbite $mic, low omtalality~ and Croup C 
iabrxd (mmionic, bw mnmtality). IO viva plnte!+t alphagranule 
release ad tibrtwl fwnrtiw were -red by radttrmnu,,.,. 
awy of beta-thrmnboglobutin a d %hrtnoppptiie A in peripheral 
*enoIls ampk9. 
The intmduction of nonionic contrast media for angiography 
has been a significant advance (1.2). However. the hemody- 
namic advantages cl nonionic contrast media over conven- 
tional ionic. high osmolrdity contrast media during routine 
attgiography have been tempered by the high cost and 
repotis of prothrombotic effects of these agents. Nanionic 
contrast media are suggested to ewe increased thromboem- 
bolism during cardiic catheterization 13.4). In vitro stud!es 
(5-g) also suggest that they are asuxiated with incressed 
platelet aggregation. loss of anticoagulant effect and in- 
creased clot formation: however. their in viva effects have 
not been well studied. Therefore, we conducted a prospec- 
tive randomized study during cardiac catheteriration to 
compare the effects on platelet activation and fibrin fomm- 
tion of a conventional contrast medium with those of newer 
nonionic contrast media. Markers of platelet acttvation 
(beta-thromboglobulin) and fibrin formation (fibrinopeptide 
A) were measured by radioimtnunoassay hefore and after 
mutine cardiac catheterization. Beta-thrombogiobulin is B 
specific marker for platelet alpha-granule rrleare (9.101. 
Fibrinopeptide A is a 16 amino wd peptide that ii cleaved 
from fibrinogen by thrombin and reRects fibrin-l formarion 
(ll.l?). 
Methods 
Study patients. The study group consisted of 30 consec- 
ulive padents undergoing routine diagnostic left heart angi- 
ography lcoronw awiwaphy and left ventriculopraphy). 
The group included I4 m;n and 16 women with a mean age 
of 58 wars (rana 42 to 78). Patients weviouslv receivina 
hepario. wrfari~or aspirin therapy and.patients with known 
thmmboembolic disorders. a prosthetic valve. a pem~anent 
pacemaker. valvular disease. cardiomyopa!hy, previous 
myocardial infarction. unstable angina or renal faiture were 
excluded from the study. The patients‘ medical regimen was 
unaltered during the study. Of the 65 patients surveyed, 35 
were excluded from the study because of the presence of 
recent myocardial infarction in I I and unstable angina in 6. 
the use ul anticoagulant or antiplatelet agents in I2 and other 
reasons t” 6. 
The 30 patients were randomized to three groups of IO 
patient, each: Gmup A received diatrizoate megtumine and 
diatrwoate c&urn 370 (ionic. high oemalaliry~. Group B 
received ioxaalate 320 (ionic. low osmalalitv) and Gmup C 
received iohe& 3W (nanionic, low osm&ty) during car- 
diac catheterization. The operators were aware of the COD 
trast medium used during Ihe procedure. Infomted consent 
was obtained from all patients for participation in ths study 
according to a protocol approved by le Committee on 
Human Investigation at our institution. 
Cardiac catbetertratia. Left hean catheterization was 
performed by srandard ludkins technique with use of 7F 
USC1 nycwe lpolyuretbane overjacket and nylon inner core) 
catheters. Both the femoral artery and vein were cannulated 
with IIF Teflon sheaths (USCI) by standard Seldinger!ech- 
nique and 7F piglail caheters were mserted over a wire 
c~em. Before entry of the ptplail catheter into the left 
v&lriclc. heparin l3kiI U) &;delivered into the venous 
system. Left vemriculoclraphy. performed with use of 45 ml 
ofconlraat medium. WBF followed by right coronary angiog- 
raphy in Iwo orthogonal views and left coronary angiography 
in at least four projections. The total time required for 
angiography after insertion of shealhs to the last kit com- 
nary angiogram was noted lmcan 20 min. range 14 to 31). 
The total volume of cootrat medium used for the group 
averaged 85 ml (range 65 10 IOSI. 
Blood processing and radioimmunoassay. Peripheral 
venous h’ood samples were collected with a 21 gauge scalp 
vein needle from an amecubital vein: a separate venipunc- 
tore wac used for each sample. Only samples obtained from 
venipunctures followed by smooth Row of blood were uli- 
lizcd. Blued samples were rejected if a hemaloma devel- 
opcd. blood Row stopped on wilhdrawal or the plasma after 
centrifuging showed hemolysis. Venous blood (9 ml) was 
~?thdrown inlo a ill ml polypropylene syringe and immedi- 
ately Iran&red ‘o a tube containing I ml of the following 
anticoagulant ~olu1mn: 0.10 M sodium chloride, 0.05 M 
HEPES butTer(pH 7.4). I.400 U/ml hepsrin. 10 mM adeno- 
gine. 20 mM lheophylline and I .OOO U/ml aprotkin (Frasylol) 
(FBA Pharmaceuticals. Inc.). Blood samples were immedi. 
alely placed on melting ice and within I h were cenlrifuged at 
3.wO g and 4’C for 20 min. The supemakant plasma was 
tnn,ferred lo polypropylene lubes with I siliconized pipette 
and centrifuged al 49.MKl p for I5 min at 4°C. The resulting 
platelet-poor plasma WRS stored frozen ot -WC. Fibrin- 
opeptide A and beta-thromboglobulin levels were measured 
by rddioimmunoassayasde~cribed previously(lO.lfl. Three 
bets of data were estimated for bo!h beta-thromboglobulin 
and Rbrinopeptide A for each paliem. ?hese were collected 
afkr insenion of the femoral sheaths and after hepariniza- 
lion. immediately after left ventriculography and later after 
the last coronary angiogram. 
Statistical analysis. Plasma levels of fibrinopeptide A and 
bekrhromboglobulm were analyzed after logarithmic trans. 
formation and reported as geomewic mean values and skm. 
dard errors of the geometric mean. The ratio of levels before 
and after left venlriculography and belore left venwiculogra- 
phy and after coronary angiography were compared among 
the three groupr by analysis of variance. A p value < 0.05 
was considered significant 
Fibrinopeptide and bela.thmmhoglobulin Iweb. There 
were no atavistically significant diRerencc5 among the three 
group\ when the ratio of Abrmopcptide levels was compared 
either before and after left ventriculography (Fig. II or 
before left vestnculography and after coronary angiography 
(Fig. 2). S’milarly. there were no slalistically sigcificant 
differences among thr three groups when the ratio of beta- 
Figure 1. Comparison or levels of fibrinopeptidc A (FPA) (pmollml) 
before (PREi and ar,er IPOST) left ventriculography among fhe 
lhree groups 110 padents in each group). No s,:,is,ically significant 
dii%rencer were found when the ratio of levels for the tbme I~WDP 
was compared. 
thromboglobulin levels was ccmpared for the same periods 
(Fig. 3 and 4). 
Discussion 
Conventional ionic radiocontrast media infusions are 
associated with a variety of adverse reactions as outlined in 
a recen, review 113). The r.ewer nonionic, low ormolalit? 
contrast media have been recognized in clinical studies (1.2) 
as less chemotoxic. as causing less hemodynamic impair- 
ment and as more biacompatible in vitro than ionic contrast 
media. However. il was recently suggested that the use of 
nonionic conhast media may be associated with an increased 
incidence of thromboemboiic complications. Robenson (3) 
suggested that there is enhanced blood clot formation in 
an&graphic syringes containing nonionic than in those 
conlaining ionic contrast medium. Grollman et al. (4) re- 
ported lhromboembolic complications occurring dcring di- 
Figure 2. Comparison of levels of fibrinopeplide A ,PPAj (pmollmll 
helore Ien ven,riculogmphy ,PRE, and afier coronary sngiography 
ILATERI among Ihe three groups (IO palienfs in each group). No 
r,a,is,ically significant diBerences were found when the ratto of 
levels lor ,he three gro”p~ was coropared. 
Rgorc 3. Comparison of levels of beta-thromboglobuhn (BTG) 
,ngirnl, beiore ,PRE, and after ,poST, left r~ntnculogmphy among 
the three groups (to patwos in each groupl. No statistic& $nC 
icant d&fencer were found when the ratio of levelr for the three 
groups was compared. 
agnostic coronary arteriography in three patients de$pife 
prior heparinization. 
Repwled lhrombotic eUectr of nonionic cootrest media. 
Although in vitro evidence suggests that ionic contrast media 
tend to have a greater anticoagulant effect than do noniomc 
media. there are few supportive data to viva G-71. Cootrat 
media have several effects on the hemostatic system. with 
the putative mechanism being binding of individual enzymes 
and inhibition of fibrin wlymerization (6). Contrast me&a 
inhibil platelet aggreg&on in vitro and in viva (6). may 
damage the endothelium at the inlection site because of high 
osmo~ality and may activate c&ulation. iibrinolytic and 
kallikrein systems. Dawaon et al. (51 in in vitro ctudies 
reported that all cootrast media inhibit platelet aggregation 
and fibrin fortoation but cattse no direct activa.ion of fibrino- 
lysis. Stormoken el al. (61 io an io vitro and in viva study 
during cerebral angiography observed a negligible influence 
of conttad~t medium on systemic hemostatic variables. but 
catheter-derived samples indicated the need for premedica- 
Figare 4. Comparison of levels of beta-tbromboglobolin IBTGI 
!n&l) before left ventriculograpt,y IPRE) and after corunwy an&i. 
ography (LATER) among the three groups (10 patients in each 
group). No statistically significant differences were found when the 
ratio of levels for the three groups war compared. 
ttoo wih arpmn or hcparin Kogko et al. 171 observed 
thrombin gcncration in acontra agent-uholc blood nuxure 
I” I” \‘:tro exper~meets and noted ttat iuhrrol ney p:rm~ 
thrombm gccncrat~oo to occur in Go. Our study showed 
no ry\termc difference in bewhromboglobulm or fibrin- 
uprptide lr~els. wggesting no ddTerence m platelet active- 
don or Fibrin fomution ti wvo. not unlike the study of 
Srormokcn et al. (61. To ?!Ivm for ~lnat~onc in andaciual 
acnratmn of these levels during cathetenution. the rauo 
of Icvcl, rather than the abwlae levels uas compared 
among the three study group,. In addilion. the volume of 
cootrat msdwm utilized and the time between estimatmn of 
lewll were not ditTerent for the three groop~ and the 
cathetenration protocol was kept rigorously Gmilar for all 
patients. No clinical thromboemholu event occurred during 
our wdiea. 
Limitations of study. The lack of slatisticall) significant 
di&rmcer in Go. as in the Jrudy of Stomwken et al. (6). 
suggeest~ hat the concentntion\ in !tvo may be too small to 
reflect dilrences in vitro. The use Jefore angiognphy of 
hepann. which IP an effective inhibitor of thrombtn and other 
enzyme prccorsors in the coagulation sybtem. may rariably 
alter levels of release of these enzymes. Although this study 
dnd not \how enhanced systemic plateletactivationand fihnn 
formation among the vanoos conrra~t media. other site5 of 
meaowmcntr. downstream of the cornnary artery or in the 
coronary sinus. may show dilierencer. This would test the 
mechanism of :“ioibus iormatwn by interplay of non~omc 
cotmast med~m and endothelium. In addition. esnmaoon~ 
of thrumhin and thrombin-antohrombin complex may dem- 
onstrate Gbition of fibrin polymenzation rather than of 
fibnnopeptide A. 
Clinical implicstians. Although this study $hows no ~yr- 
temic ditTerences in platelel activaion and fibrin formation 
between ionic and oooiooic contrast media. core tmn! be 
taken when nonionic cootrat media are used dunng cardiac 
or ccrebtal angiognpby. Cantmuaus Rurbing with saline 
solution to prevenl midng of blood and contrast medium. 
premedtcation with heparin and USC of plastic syringes 
remain important recommendations for the safe USC of 
nonion~c ontwt media. Larger randomized clinical trials 
ore reqcired to conclusively determine the suggested throm- 
boembolic pulential of ttcnionic contrast media. 

